Translational Research Partnerships in Biomedical Engineering   After an extensive application and selection process during the summer of 2005, the Foundation announced in October, the names of the nine Universities selected to receive the Translational Research Partnership Award in Biomedical Engineering in addition to the already existing program at Georgia Tech and Emory.   The recipients are the following:   ...Boston University, Boston, MA ...Case Western Reserve University, Cleveland, OH ...Drexel University, Philadelphia, PA ...Duke University, Durham, NC ...Stanford University, Stanford, CA ...University of Michigan, Ann Arbor, MI ...University of Virginia, Charlottesville, VA ...University of Washington, Seattle, WA ...University of Wisconsin, Madison, WI   Their names and the title of their projects : Translational Research Partnership Award Recipients   The Biomedical Engineering Department Chair is considered the Principle Investigator of the Award. Each school established an Oversight Committee, consisting of stake holders in the translational process. It includes the BME Department Chair, representatives from the medical school, the Office of Technology Transfer, entrepreneurs, local Venture Capital, and the Business school. Additionally, the grant provides funding for a Coulter Project Director to oversee the daily operations of the award. This Award provides $580,000 each year for a period of five years. With this Award, the Foundation will form a working partnership with the Biomedical Engineering Department to promote translational research. This will be achieved by increasing the number and effective collaborations between biomedical engineers and clinicians, supporting the movement of promising technologies to clinical application, and developing sustainable processes. The Translational Research Partner Institutions will work closely with the Foundation to promote, develop and realize the clinical potential of translational research. The ultimate goal of this partnership is to focus on outcomes which will save, extend, and improve patient lives suffering from any disease or condition, in any size market, in any discipline, in any country around the world.